CD44: A cancer stem cell-related biomarker with predictive potential for radiotherapy
Publikation: Beitrag in Fachzeitschrift › Kommentar (Comment) / Leserbriefe ohne eigene Daten › Beigetragen › Begutachtung
Beitragende
Abstract
CD44, a cancer stem cell (CSC)-related surface marker, correlates with local control after radiotherapy of early laryngeal cancer. For the first time, a CSC-related marker has been functionally validated for radiotherapy in patients. CD44 expression bears the potential to predict the outcome of radiotherapy by assessment of CSC density.
Details
| Originalsprache | Englisch |
|---|---|
| Seiten (von - bis) | 5091-5093 |
| Seitenumfang | 3 |
| Fachzeitschrift | Clinical cancer research |
| Jahrgang | 16 |
| Ausgabenummer | 21 |
| Publikationsstatus | Veröffentlicht - 1 Nov. 2010 |
| Peer-Review-Status | Ja |
Externe IDs
| PubMed | 20861165 |
|---|---|
| ORCID | /0000-0003-1776-9556/work/171065839 |